共 211 条
[1]
Koga K(2003)Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGR-1) levels in women with preeclampsia J Clin Endocrinol Metab 88 2348-51
[2]
Osuga Y(2006)Soluble endoglin and other circulating anti-angiogenic factors in preeclampsia N Engl J Med 355 992-1005
[3]
Yoshino O(2007)Sequential changes in anti-angiogenic factors in early pregnancy and risk of developing preeclampsia Hypertension 50 137-42
[4]
Levine RJ(1996)Blood clotting activation during normal pregnancy Thromb Res 84 199-202
[5]
Lam C(1997)Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis Eur J Obstet Gynecol Reprod Biol 73 31-6
[6]
Qian C(2013)Task Force on Hypertension in Pregnancy Obstet Gynecol 122 1122-31
[7]
Rana S(2009)Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period Thromb Res 123 S63-4
[8]
Karumananchi SA(2005)Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies BMJ 330 565-72
[9]
Levine RJ(2005)A sister’s risk: family history as a predictor of preeclampsia Am J Obstet Gynecol 193 965-24
[10]
Comeglio P(2015)Preeclampsia: syndrome or disease? Curr Hypertens Rep 17 83-76